nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxetine—ALB—hepatitis B	0.575	1	CbGaD
Fluoxetine—ORM1—saliva—hepatitis B	0.0111	0.186	CbGeAlD
Fluoxetine—SLC6A4—blood plasma—hepatitis B	0.00413	0.0688	CbGeAlD
Fluoxetine—CYP2C19—blood plasma—hepatitis B	0.00342	0.057	CbGeAlD
Fluoxetine—Musculoskeletal stiffness—Telbivudine—hepatitis B	0.00287	0.00899	CcSEcCtD
Fluoxetine—CYP1A2—blood plasma—hepatitis B	0.0028	0.0466	CbGeAlD
Fluoxetine—Suicide—Lamivudine—hepatitis B	0.00279	0.00877	CcSEcCtD
Fluoxetine—Creatine phosphokinase increased—Lamivudine—hepatitis B	0.00276	0.00865	CcSEcCtD
Fluoxetine—CYP3A5—blood plasma—hepatitis B	0.0027	0.0449	CbGeAlD
Fluoxetine—CYP2B6—blood plasma—hepatitis B	0.00268	0.0447	CbGeAlD
Fluoxetine—CYP2C9—blood plasma—hepatitis B	0.00265	0.0442	CbGeAlD
Fluoxetine—Neck pain—Telbivudine—hepatitis B	0.0026	0.00817	CcSEcCtD
Fluoxetine—Pregnancy—Lamivudine—hepatitis B	0.00255	0.00801	CcSEcCtD
Fluoxetine—Gingival bleeding—Lamivudine—hepatitis B	0.00255	0.00801	CcSEcCtD
Fluoxetine—Suicide attempt—Lamivudine—hepatitis B	0.00255	0.00801	CcSEcCtD
Fluoxetine—Hepatic failure—Entecavir—hepatitis B	0.00253	0.00793	CcSEcCtD
Fluoxetine—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.00247	0.00774	CcSEcCtD
Fluoxetine—Completed suicide—Lamivudine—hepatitis B	0.00246	0.00773	CcSEcCtD
Fluoxetine—Anaphylactoid reaction—Entecavir—hepatitis B	0.00235	0.00737	CcSEcCtD
Fluoxetine—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.00233	0.00731	CcSEcCtD
Fluoxetine—Hypoxia—Lamivudine—hepatitis B	0.00228	0.00716	CcSEcCtD
Fluoxetine—Breast enlargement—Lamivudine—hepatitis B	0.00223	0.00701	CcSEcCtD
Fluoxetine—HTR2A—blood plasma—hepatitis B	0.00219	0.0364	CbGeAlD
Fluoxetine—Blood creatine phosphokinase increased—Lamivudine—hepatitis B	0.00211	0.00661	CcSEcCtD
Fluoxetine—Myopathy—Lamivudine—hepatitis B	0.00207	0.00648	CcSEcCtD
Fluoxetine—Hepatomegaly—Lamivudine—hepatitis B	0.00205	0.00642	CcSEcCtD
Fluoxetine—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.00205	0.00642	CcSEcCtD
Fluoxetine—CYP3A4—blood plasma—hepatitis B	0.00202	0.0337	CbGeAlD
Fluoxetine—CYP2D6—blood plasma—hepatitis B	0.00199	0.0332	CbGeAlD
Fluoxetine—Renal impairment—Telbivudine—hepatitis B	0.00196	0.00615	CcSEcCtD
Fluoxetine—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00195	0.00614	CcSEcCtD
Fluoxetine—Pancreatitis—Entecavir—hepatitis B	0.00192	0.00604	CcSEcCtD
Fluoxetine—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00188	0.00589	CcSEcCtD
Fluoxetine—Amblyopia—Lamivudine—hepatitis B	0.00188	0.00589	CcSEcCtD
Fluoxetine—Hyperaesthesia—Lamivudine—hepatitis B	0.00185	0.00579	CcSEcCtD
Fluoxetine—Migraine—Telbivudine—hepatitis B	0.00184	0.00577	CcSEcCtD
Fluoxetine—Upper respiratory tract infection—Entecavir—hepatitis B	0.00182	0.00573	CcSEcCtD
Fluoxetine—ORM1—blood—hepatitis B	0.00178	0.0296	CbGeAlD
Fluoxetine—Hyperglycaemia—Entecavir—hepatitis B	0.00177	0.00556	CcSEcCtD
Fluoxetine—Blood disorder—Lamivudine—hepatitis B	0.00173	0.00544	CcSEcCtD
Fluoxetine—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00173	0.00544	CcSEcCtD
Fluoxetine—Acne—Lamivudine—hepatitis B	0.00172	0.0054	CcSEcCtD
Fluoxetine—Renal failure—Entecavir—hepatitis B	0.00172	0.0054	CcSEcCtD
Fluoxetine—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00168	0.00527	CcSEcCtD
Fluoxetine—Haematuria—Entecavir—hepatitis B	0.00167	0.00524	CcSEcCtD
Fluoxetine—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00166	0.00523	CcSEcCtD
Fluoxetine—Gastritis—Telbivudine—hepatitis B	0.00165	0.00518	CcSEcCtD
Fluoxetine—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00165	0.00517	CcSEcCtD
Fluoxetine—Muscular weakness—Telbivudine—hepatitis B	0.00165	0.00517	CcSEcCtD
Fluoxetine—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00163	0.00511	CcSEcCtD
Fluoxetine—Abdominal distension—Telbivudine—hepatitis B	0.00162	0.0051	CcSEcCtD
Fluoxetine—Influenza—Telbivudine—hepatitis B	0.00161	0.00506	CcSEcCtD
Fluoxetine—Rectal haemorrhage—Lamivudine—hepatitis B	0.0016	0.00503	CcSEcCtD
Fluoxetine—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.0016	0.00503	CcSEcCtD
Fluoxetine—Hepatitis—Entecavir—hepatitis B	0.00157	0.00493	CcSEcCtD
Fluoxetine—Drug interaction—Lamivudine—hepatitis B	0.00156	0.0049	CcSEcCtD
Fluoxetine—Oedema peripheral—Entecavir—hepatitis B	0.00155	0.00486	CcSEcCtD
Fluoxetine—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00153	0.00481	CcSEcCtD
Fluoxetine—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00153	0.00481	CcSEcCtD
Fluoxetine—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00152	0.00478	CcSEcCtD
Fluoxetine—SLC6A4—blood—hepatitis B	0.00151	0.0252	CbGeAlD
Fluoxetine—SIGMAR1—blood—hepatitis B	0.0015	0.025	CbGeAlD
Fluoxetine—Upper respiratory tract infection—Telbivudine—hepatitis B	0.0015	0.00471	CcSEcCtD
Fluoxetine—Vasculitis—Lamivudine—hepatitis B	0.00148	0.00466	CcSEcCtD
Fluoxetine—Muscle twitching—Lamivudine—hepatitis B	0.00148	0.00463	CcSEcCtD
Fluoxetine—ABCB1—blood plasma—hepatitis B	0.00143	0.0239	CbGeAlD
Fluoxetine—Eructation—Lamivudine—hepatitis B	0.00142	0.00447	CcSEcCtD
Fluoxetine—Renal failure—Telbivudine—hepatitis B	0.00141	0.00444	CcSEcCtD
Fluoxetine—Neuropathy peripheral—Telbivudine—hepatitis B	0.00141	0.00442	CcSEcCtD
Fluoxetine—ORM1—liver—hepatitis B	0.00139	0.0231	CbGeAlD
Fluoxetine—Alopecia—Entecavir—hepatitis B	0.00139	0.00436	CcSEcCtD
Fluoxetine—Mental disorder—Entecavir—hepatitis B	0.00138	0.00432	CcSEcCtD
Fluoxetine—Malnutrition—Entecavir—hepatitis B	0.00137	0.00429	CcSEcCtD
Fluoxetine—Photophobia—Lamivudine—hepatitis B	0.00136	0.00427	CcSEcCtD
Fluoxetine—Aplastic anaemia—Lamivudine—hepatitis B	0.00136	0.00427	CcSEcCtD
Fluoxetine—Neuropathy—Lamivudine—hepatitis B	0.00136	0.00427	CcSEcCtD
Fluoxetine—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00133	0.00419	CcSEcCtD
Fluoxetine—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00132	0.00413	CcSEcCtD
Fluoxetine—Urine output increased—Lamivudine—hepatitis B	0.00131	0.00411	CcSEcCtD
Fluoxetine—Mouth ulceration—Lamivudine—hepatitis B	0.00131	0.00411	CcSEcCtD
Fluoxetine—Gynaecomastia—Lamivudine—hepatitis B	0.0013	0.00407	CcSEcCtD
Fluoxetine—Back pain—Adefovir Dipivoxil—hepatitis B	0.00129	0.00405	CcSEcCtD
Fluoxetine—Hepatitis—Telbivudine—hepatitis B	0.00129	0.00405	CcSEcCtD
Fluoxetine—Hypoaesthesia—Telbivudine—hepatitis B	0.00128	0.00403	CcSEcCtD
Fluoxetine—Pharyngitis—Telbivudine—hepatitis B	0.00128	0.00402	CcSEcCtD
Fluoxetine—CYP2C19—blood—hepatitis B	0.00125	0.0209	CbGeAlD
Fluoxetine—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00123	0.00387	CcSEcCtD
Fluoxetine—Lymphadenopathy—Lamivudine—hepatitis B	0.00123	0.00387	CcSEcCtD
Fluoxetine—Leukopenia—Entecavir—hepatitis B	0.00122	0.00384	CcSEcCtD
Fluoxetine—Phlebitis—Lamivudine—hepatitis B	0.00122	0.00383	CcSEcCtD
Fluoxetine—ALB—liver—hepatitis B	0.00122	0.0203	CbGeAlD
Fluoxetine—Sleep disorder—Lamivudine—hepatitis B	0.00121	0.00381	CcSEcCtD
Fluoxetine—Polyuria—Lamivudine—hepatitis B	0.0012	0.00376	CcSEcCtD
Fluoxetine—Gastroenteritis—Lamivudine—hepatitis B	0.00119	0.00372	CcSEcCtD
Fluoxetine—Deafness—Lamivudine—hepatitis B	0.00118	0.00369	CcSEcCtD
Fluoxetine—SIGMAR1—liver—hepatitis B	0.00118	0.0196	CbGeAlD
Fluoxetine—Cough—Adefovir Dipivoxil—hepatitis B	0.00116	0.00366	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00116	0.00363	CcSEcCtD
Fluoxetine—Injury—Lamivudine—hepatitis B	0.00114	0.00359	CcSEcCtD
Fluoxetine—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00114	0.00357	CcSEcCtD
Fluoxetine—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00114	0.00357	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00113	0.00354	CcSEcCtD
Fluoxetine—Malnutrition—Telbivudine—hepatitis B	0.00112	0.00353	CcSEcCtD
Fluoxetine—Anaphylactic shock—Entecavir—hepatitis B	0.00112	0.0035	CcSEcCtD
Fluoxetine—Infection—Entecavir—hepatitis B	0.00111	0.00348	CcSEcCtD
Fluoxetine—Thirst—Lamivudine—hepatitis B	0.00111	0.00347	CcSEcCtD
Fluoxetine—Renal impairment—Lamivudine—hepatitis B	0.00111	0.00347	CcSEcCtD
Fluoxetine—Dysgeusia—Telbivudine—hepatitis B	0.0011	0.00345	CcSEcCtD
Fluoxetine—Back pain—Telbivudine—hepatitis B	0.00109	0.00341	CcSEcCtD
Fluoxetine—Skin disorder—Entecavir—hepatitis B	0.00108	0.0034	CcSEcCtD
Fluoxetine—Muscle spasms—Telbivudine—hepatitis B	0.00108	0.00339	CcSEcCtD
Fluoxetine—Hypoglycaemia—Lamivudine—hepatitis B	0.00108	0.00338	CcSEcCtD
Fluoxetine—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00107	0.00335	CcSEcCtD
Fluoxetine—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00106	0.00332	CcSEcCtD
Fluoxetine—Ill-defined disorder—Telbivudine—hepatitis B	0.00104	0.00327	CcSEcCtD
Fluoxetine—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00104	0.00326	CcSEcCtD
Fluoxetine—Migraine—Lamivudine—hepatitis B	0.00104	0.00325	CcSEcCtD
Fluoxetine—Affect lability—Lamivudine—hepatitis B	0.00104	0.00325	CcSEcCtD
Fluoxetine—CYP1A2—blood—hepatitis B	0.00102	0.0171	CbGeAlD
Fluoxetine—Malaise—Telbivudine—hepatitis B	0.00101	0.00318	CcSEcCtD
Fluoxetine—Insomnia—Entecavir—hepatitis B	0.00101	0.00317	CcSEcCtD
Fluoxetine—Mood swings—Lamivudine—hepatitis B	0.000996	0.00313	CcSEcCtD
Fluoxetine—Somnolence—Entecavir—hepatitis B	0.000993	0.00312	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.000992	0.00312	CcSEcCtD
Fluoxetine—CYP3A5—blood—hepatitis B	0.000988	0.0165	CbGeAlD
Fluoxetine—Dyspepsia—Entecavir—hepatitis B	0.000983	0.00308	CcSEcCtD
Fluoxetine—CYP2B6—blood—hepatitis B	0.000982	0.0164	CbGeAlD
Fluoxetine—CYP2C19—liver—hepatitis B	0.000981	0.0163	CbGeAlD
Fluoxetine—Cough—Telbivudine—hepatitis B	0.000981	0.00308	CcSEcCtD
Fluoxetine—Dehydration—Lamivudine—hepatitis B	0.000978	0.00307	CcSEcCtD
Fluoxetine—CYP2C9—blood—hepatitis B	0.000972	0.0162	CbGeAlD
Fluoxetine—Liver function test abnormal—Lamivudine—hepatitis B	0.000971	0.00305	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Entecavir—hepatitis B	0.000964	0.00303	CcSEcCtD
Fluoxetine—Fatigue—Entecavir—hepatitis B	0.000963	0.00302	CcSEcCtD
Fluoxetine—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.000959	0.00301	CcSEcCtD
Fluoxetine—Myalgia—Telbivudine—hepatitis B	0.000957	0.003	CcSEcCtD
Fluoxetine—Arthralgia—Telbivudine—hepatitis B	0.000957	0.003	CcSEcCtD
Fluoxetine—Chest pain—Telbivudine—hepatitis B	0.000957	0.003	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00095	0.00298	CcSEcCtD
Fluoxetine—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.000947	0.00297	CcSEcCtD
Fluoxetine—Discomfort—Telbivudine—hepatitis B	0.000945	0.00297	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00094	0.00295	CcSEcCtD
Fluoxetine—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.000928	0.00291	CcSEcCtD
Fluoxetine—Muscular weakness—Lamivudine—hepatitis B	0.000928	0.00291	CcSEcCtD
Fluoxetine—Abdominal distension—Lamivudine—hepatitis B	0.000915	0.00287	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Entecavir—hepatitis B	0.000913	0.00287	CcSEcCtD
Fluoxetine—Influenza—Lamivudine—hepatitis B	0.000909	0.00285	CcSEcCtD
Fluoxetine—Dysphagia—Lamivudine—hepatitis B	0.000909	0.00285	CcSEcCtD
Fluoxetine—Thrombocytopenia—Telbivudine—hepatitis B	0.000898	0.00282	CcSEcCtD
Fluoxetine—Pancreatitis—Lamivudine—hepatitis B	0.000891	0.0028	CcSEcCtD
Fluoxetine—Skin disorder—Telbivudine—hepatitis B	0.000891	0.0028	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.000891	0.0028	CcSEcCtD
Fluoxetine—Sweating increased—Lamivudine—hepatitis B	0.000885	0.00278	CcSEcCtD
Fluoxetine—Abdominal pain—Entecavir—hepatitis B	0.000883	0.00277	CcSEcCtD
Fluoxetine—Body temperature increased—Entecavir—hepatitis B	0.000883	0.00277	CcSEcCtD
Fluoxetine—Bronchitis—Lamivudine—hepatitis B	0.000874	0.00274	CcSEcCtD
Fluoxetine—Pancytopenia—Lamivudine—hepatitis B	0.000863	0.00271	CcSEcCtD
Fluoxetine—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.000861	0.0027	CcSEcCtD
Fluoxetine—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.000861	0.0027	CcSEcCtD
Fluoxetine—Dysuria—Lamivudine—hepatitis B	0.00085	0.00267	CcSEcCtD
Fluoxetine—Pollakiuria—Lamivudine—hepatitis B	0.00084	0.00264	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.000836	0.00262	CcSEcCtD
Fluoxetine—Insomnia—Telbivudine—hepatitis B	0.00083	0.0026	CcSEcCtD
Fluoxetine—Paraesthesia—Telbivudine—hepatitis B	0.000824	0.00259	CcSEcCtD
Fluoxetine—Hyperglycaemia—Lamivudine—hepatitis B	0.00082	0.00257	CcSEcCtD
Fluoxetine—Depression—Lamivudine—hepatitis B	0.000808	0.00254	CcSEcCtD
Fluoxetine—Dyspepsia—Telbivudine—hepatitis B	0.000807	0.00253	CcSEcCtD
Fluoxetine—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.000803	0.00252	CcSEcCtD
Fluoxetine—CYP1A2—liver—hepatitis B	0.000801	0.0133	CbGeAlD
Fluoxetine—Asthenia—Entecavir—hepatitis B	0.000801	0.00251	CcSEcCtD
Fluoxetine—HTR2A—blood—hepatitis B	0.000801	0.0133	CbGeAlD
Fluoxetine—Renal failure—Lamivudine—hepatitis B	0.000797	0.0025	CcSEcCtD
Fluoxetine—Neuropathy peripheral—Lamivudine—hepatitis B	0.000794	0.00249	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Telbivudine—hepatitis B	0.000792	0.00249	CcSEcCtD
Fluoxetine—Fatigue—Telbivudine—hepatitis B	0.000791	0.00248	CcSEcCtD
Fluoxetine—Stomatitis—Lamivudine—hepatitis B	0.00079	0.00248	CcSEcCtD
Fluoxetine—Jaundice—Lamivudine—hepatitis B	0.00079	0.00248	CcSEcCtD
Fluoxetine—Pain—Telbivudine—hepatitis B	0.000784	0.00246	CcSEcCtD
Fluoxetine—Asthenia—Adefovir Dipivoxil—hepatitis B	0.000782	0.00245	CcSEcCtD
Fluoxetine—Sweating—Lamivudine—hepatitis B	0.000777	0.00244	CcSEcCtD
Fluoxetine—CYP3A5—liver—hepatitis B	0.000773	0.0129	CbGeAlD
Fluoxetine—Pruritus—Adefovir Dipivoxil—hepatitis B	0.000771	0.00242	CcSEcCtD
Fluoxetine—CYP2B6—liver—hepatitis B	0.000768	0.0128	CbGeAlD
Fluoxetine—Epistaxis—Lamivudine—hepatitis B	0.000764	0.0024	CcSEcCtD
Fluoxetine—Diarrhoea—Entecavir—hepatitis B	0.000764	0.0024	CcSEcCtD
Fluoxetine—CYP2C9—liver—hepatitis B	0.00076	0.0127	CbGeAlD
Fluoxetine—Sinusitis—Lamivudine—hepatitis B	0.00076	0.00239	CcSEcCtD
Fluoxetine—Feeling abnormal—Telbivudine—hepatitis B	0.000756	0.00237	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Telbivudine—hepatitis B	0.00075	0.00235	CcSEcCtD
Fluoxetine—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.000745	0.00234	CcSEcCtD
Fluoxetine—CYP3A4—blood—hepatitis B	0.000742	0.0124	CbGeAlD
Fluoxetine—Dizziness—Entecavir—hepatitis B	0.000738	0.00232	CcSEcCtD
Fluoxetine—CYP2D6—blood—hepatitis B	0.00073	0.0122	CbGeAlD
Fluoxetine—Rhinitis—Lamivudine—hepatitis B	0.000729	0.00229	CcSEcCtD
Fluoxetine—Hepatitis—Lamivudine—hepatitis B	0.000728	0.00228	CcSEcCtD
Fluoxetine—Abdominal pain—Telbivudine—hepatitis B	0.000725	0.00228	CcSEcCtD
Fluoxetine—Body temperature increased—Telbivudine—hepatitis B	0.000725	0.00228	CcSEcCtD
Fluoxetine—Hypoaesthesia—Lamivudine—hepatitis B	0.000724	0.00227	CcSEcCtD
Fluoxetine—Pharyngitis—Lamivudine—hepatitis B	0.000722	0.00227	CcSEcCtD
Fluoxetine—Vomiting—Entecavir—hepatitis B	0.00071	0.00223	CcSEcCtD
Fluoxetine—Rash—Entecavir—hepatitis B	0.000704	0.00221	CcSEcCtD
Fluoxetine—Dermatitis—Entecavir—hepatitis B	0.000703	0.00221	CcSEcCtD
Fluoxetine—Headache—Entecavir—hepatitis B	0.000699	0.0022	CcSEcCtD
Fluoxetine—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000693	0.00217	CcSEcCtD
Fluoxetine—Erythema multiforme—Lamivudine—hepatitis B	0.000688	0.00216	CcSEcCtD
Fluoxetine—Rash—Adefovir Dipivoxil—hepatitis B	0.000687	0.00216	CcSEcCtD
Fluoxetine—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000686	0.00215	CcSEcCtD
Fluoxetine—Headache—Adefovir Dipivoxil—hepatitis B	0.000682	0.00214	CcSEcCtD
Fluoxetine—Nausea—Entecavir—hepatitis B	0.000663	0.00208	CcSEcCtD
Fluoxetine—Asthenia—Telbivudine—hepatitis B	0.000658	0.00207	CcSEcCtD
Fluoxetine—Chills—Lamivudine—hepatitis B	0.000653	0.00205	CcSEcCtD
Fluoxetine—Pruritus—Telbivudine—hepatitis B	0.000649	0.00204	CcSEcCtD
Fluoxetine—Nausea—Adefovir Dipivoxil—hepatitis B	0.000647	0.00203	CcSEcCtD
Fluoxetine—Alopecia—Lamivudine—hepatitis B	0.000643	0.00202	CcSEcCtD
Fluoxetine—Malnutrition—Lamivudine—hepatitis B	0.000633	0.00199	CcSEcCtD
Fluoxetine—Diarrhoea—Telbivudine—hepatitis B	0.000628	0.00197	CcSEcCtD
Fluoxetine—HTR2A—liver—hepatitis B	0.000626	0.0104	CbGeAlD
Fluoxetine—Flatulence—Lamivudine—hepatitis B	0.000624	0.00196	CcSEcCtD
Fluoxetine—Tension—Lamivudine—hepatitis B	0.000621	0.00195	CcSEcCtD
Fluoxetine—Dysgeusia—Lamivudine—hepatitis B	0.00062	0.00195	CcSEcCtD
Fluoxetine—Nervousness—Lamivudine—hepatitis B	0.000615	0.00193	CcSEcCtD
Fluoxetine—Back pain—Lamivudine—hepatitis B	0.000613	0.00192	CcSEcCtD
Fluoxetine—Muscle spasms—Lamivudine—hepatitis B	0.000609	0.00191	CcSEcCtD
Fluoxetine—Dizziness—Telbivudine—hepatitis B	0.000607	0.0019	CcSEcCtD
Fluoxetine—Tremor—Lamivudine—hepatitis B	0.000593	0.00186	CcSEcCtD
Fluoxetine—Ill-defined disorder—Lamivudine—hepatitis B	0.000588	0.00184	CcSEcCtD
Fluoxetine—Anaemia—Lamivudine—hepatitis B	0.000585	0.00184	CcSEcCtD
Fluoxetine—Vomiting—Telbivudine—hepatitis B	0.000583	0.00183	CcSEcCtD
Fluoxetine—CYP3A4—liver—hepatitis B	0.00058	0.00966	CbGeAlD
Fluoxetine—Angioedema—Lamivudine—hepatitis B	0.000579	0.00182	CcSEcCtD
Fluoxetine—Rash—Telbivudine—hepatitis B	0.000578	0.00182	CcSEcCtD
Fluoxetine—Dermatitis—Telbivudine—hepatitis B	0.000578	0.00181	CcSEcCtD
Fluoxetine—Headache—Telbivudine—hepatitis B	0.000575	0.0018	CcSEcCtD
Fluoxetine—Malaise—Lamivudine—hepatitis B	0.000571	0.00179	CcSEcCtD
Fluoxetine—CYP2D6—liver—hepatitis B	0.000571	0.00951	CbGeAlD
Fluoxetine—Vertigo—Lamivudine—hepatitis B	0.000569	0.00179	CcSEcCtD
Fluoxetine—Syncope—Lamivudine—hepatitis B	0.000568	0.00178	CcSEcCtD
Fluoxetine—Leukopenia—Lamivudine—hepatitis B	0.000567	0.00178	CcSEcCtD
Fluoxetine—Loss of consciousness—Lamivudine—hepatitis B	0.000557	0.00175	CcSEcCtD
Fluoxetine—Cough—Lamivudine—hepatitis B	0.000553	0.00173	CcSEcCtD
Fluoxetine—Convulsion—Lamivudine—hepatitis B	0.000549	0.00172	CcSEcCtD
Fluoxetine—Nausea—Telbivudine—hepatitis B	0.000545	0.00171	CcSEcCtD
Fluoxetine—Chest pain—Lamivudine—hepatitis B	0.000539	0.00169	CcSEcCtD
Fluoxetine—Myalgia—Lamivudine—hepatitis B	0.000539	0.00169	CcSEcCtD
Fluoxetine—Arthralgia—Lamivudine—hepatitis B	0.000539	0.00169	CcSEcCtD
Fluoxetine—Anxiety—Lamivudine—hepatitis B	0.000537	0.00169	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.000535	0.00168	CcSEcCtD
Fluoxetine—Discomfort—Lamivudine—hepatitis B	0.000533	0.00167	CcSEcCtD
Fluoxetine—Dry mouth—Lamivudine—hepatitis B	0.000527	0.00166	CcSEcCtD
Fluoxetine—ABCB1—blood—hepatitis B	0.000525	0.00875	CbGeAlD
Fluoxetine—Confusional state—Lamivudine—hepatitis B	0.000521	0.00164	CcSEcCtD
Fluoxetine—Anaphylactic shock—Lamivudine—hepatitis B	0.000517	0.00162	CcSEcCtD
Fluoxetine—Infection—Lamivudine—hepatitis B	0.000514	0.00161	CcSEcCtD
Fluoxetine—Shock—Lamivudine—hepatitis B	0.000509	0.0016	CcSEcCtD
Fluoxetine—Thrombocytopenia—Lamivudine—hepatitis B	0.000506	0.00159	CcSEcCtD
Fluoxetine—Skin disorder—Lamivudine—hepatitis B	0.000502	0.00158	CcSEcCtD
Fluoxetine—Hyperhidrosis—Lamivudine—hepatitis B	0.0005	0.00157	CcSEcCtD
Fluoxetine—Anorexia—Lamivudine—hepatitis B	0.000493	0.00155	CcSEcCtD
Fluoxetine—Hypotension—Lamivudine—hepatitis B	0.000483	0.00152	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000471	0.00148	CcSEcCtD
Fluoxetine—Insomnia—Lamivudine—hepatitis B	0.000468	0.00147	CcSEcCtD
Fluoxetine—Paraesthesia—Lamivudine—hepatitis B	0.000464	0.00146	CcSEcCtD
Fluoxetine—Dyspnoea—Lamivudine—hepatitis B	0.000461	0.00145	CcSEcCtD
Fluoxetine—Somnolence—Lamivudine—hepatitis B	0.00046	0.00144	CcSEcCtD
Fluoxetine—Dyspepsia—Lamivudine—hepatitis B	0.000455	0.00143	CcSEcCtD
Fluoxetine—Decreased appetite—Lamivudine—hepatitis B	0.000449	0.00141	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000446	0.0014	CcSEcCtD
Fluoxetine—Fatigue—Lamivudine—hepatitis B	0.000446	0.0014	CcSEcCtD
Fluoxetine—Constipation—Lamivudine—hepatitis B	0.000442	0.00139	CcSEcCtD
Fluoxetine—Pain—Lamivudine—hepatitis B	0.000442	0.00139	CcSEcCtD
Fluoxetine—Feeling abnormal—Lamivudine—hepatitis B	0.000426	0.00134	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Lamivudine—hepatitis B	0.000423	0.00133	CcSEcCtD
Fluoxetine—Urticaria—Lamivudine—hepatitis B	0.000411	0.00129	CcSEcCtD
Fluoxetine—ABCB1—liver—hepatitis B	0.00041	0.00684	CbGeAlD
Fluoxetine—Body temperature increased—Lamivudine—hepatitis B	0.000409	0.00128	CcSEcCtD
Fluoxetine—Abdominal pain—Lamivudine—hepatitis B	0.000409	0.00128	CcSEcCtD
Fluoxetine—Hypersensitivity—Lamivudine—hepatitis B	0.000381	0.0012	CcSEcCtD
Fluoxetine—Asthenia—Lamivudine—hepatitis B	0.000371	0.00116	CcSEcCtD
Fluoxetine—Pruritus—Lamivudine—hepatitis B	0.000366	0.00115	CcSEcCtD
Fluoxetine—Diarrhoea—Lamivudine—hepatitis B	0.000354	0.00111	CcSEcCtD
Fluoxetine—Dizziness—Lamivudine—hepatitis B	0.000342	0.00107	CcSEcCtD
Fluoxetine—Vomiting—Lamivudine—hepatitis B	0.000329	0.00103	CcSEcCtD
Fluoxetine—Rash—Lamivudine—hepatitis B	0.000326	0.00102	CcSEcCtD
Fluoxetine—Dermatitis—Lamivudine—hepatitis B	0.000326	0.00102	CcSEcCtD
Fluoxetine—Headache—Lamivudine—hepatitis B	0.000324	0.00102	CcSEcCtD
Fluoxetine—Nausea—Lamivudine—hepatitis B	0.000307	0.000964	CcSEcCtD
Fluoxetine—SLC6A4—Circadian rythm related genes—FAS—hepatitis B	0.000132	0.00285	CbGpPWpGaD
Fluoxetine—CYP2C19—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000131	0.00284	CbGpPWpGaD
Fluoxetine—CYP3A5—Biological oxidations—CYP2A6—hepatitis B	0.00013	0.00281	CbGpPWpGaD
Fluoxetine—CYP1A2—Biological oxidations—GGT2—hepatitis B	0.000129	0.00279	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—HBE1—hepatitis B	0.000126	0.00272	CbGpPWpGaD
Fluoxetine—CYP2D6—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000121	0.00261	CbGpPWpGaD
Fluoxetine—ALB—Folate Metabolism—F2—hepatitis B	0.00012	0.0026	CbGpPWpGaD
Fluoxetine—ABCB1—Allograft Rejection—CD40LG—hepatitis B	0.000117	0.00254	CbGpPWpGaD
Fluoxetine—ABCB1—Allograft Rejection—IL10—hepatitis B	0.000117	0.00254	CbGpPWpGaD
Fluoxetine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000113	0.00246	CbGpPWpGaD
Fluoxetine—SLC6A4—Circadian rythm related genes—NOS2—hepatitis B	0.000113	0.00244	CbGpPWpGaD
Fluoxetine—ALB—Vitamin B12 Metabolism—IFNG—hepatitis B	0.000112	0.00242	CbGpPWpGaD
Fluoxetine—ABCB1—Allograft Rejection—FASLG—hepatitis B	0.000109	0.00237	CbGpPWpGaD
Fluoxetine—HTR2A—SIDS Susceptibility Pathways—IL10—hepatitis B	0.000108	0.00235	CbGpPWpGaD
Fluoxetine—ABCB1—Allograft Rejection—FAS—hepatitis B	0.000105	0.00228	CbGpPWpGaD
Fluoxetine—CYP1A2—Phase II conjugation—GGT1—hepatitis B	0.000104	0.00226	CbGpPWpGaD
Fluoxetine—ABCB1—HIF-1-alpha transcription factor network—NOS2—hepatitis B	0.000104	0.00225	CbGpPWpGaD
Fluoxetine—CYP2B6—Biological oxidations—GGT1—hepatitis B	0.000103	0.00224	CbGpPWpGaD
Fluoxetine—ABCB1—Allograft Rejection—HLA-A—hepatitis B	0.000103	0.00224	CbGpPWpGaD
Fluoxetine—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000102	0.00222	CbGpPWpGaD
Fluoxetine—CYP1A2—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000102	0.00222	CbGpPWpGaD
Fluoxetine—CYP3A5—Biological oxidations—GGT1—hepatitis B	0.000101	0.00219	CbGpPWpGaD
Fluoxetine—CYP2C19—Biological oxidations—CYP2A6—hepatitis B	0.0001	0.00217	CbGpPWpGaD
Fluoxetine—CYP3A4—Biological oxidations—GGT2—hepatitis B	9.94e-05	0.00215	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	9.56e-05	0.00207	CbGpPWpGaD
Fluoxetine—ALB—Selenium Micronutrient Network—F2—hepatitis B	9.54e-05	0.00207	CbGpPWpGaD
Fluoxetine—ABCB1—Allograft Rejection—HLA-DRB1—hepatitis B	9.45e-05	0.00205	CbGpPWpGaD
Fluoxetine—ALB—Vitamin B12 Metabolism—NFKB1—hepatitis B	9.31e-05	0.00202	CbGpPWpGaD
Fluoxetine—CYP2D6—Biological oxidations—CYP2A6—hepatitis B	9.21e-05	0.002	CbGpPWpGaD
Fluoxetine—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	9.13e-05	0.00198	CbGpPWpGaD
Fluoxetine—ALB—Folate Metabolism—IFNG—hepatitis B	9.1e-05	0.00197	CbGpPWpGaD
Fluoxetine—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	9.08e-05	0.00197	CbGpPWpGaD
Fluoxetine—SLC6A4—SIDS Susceptibility Pathways—NFKB1—hepatitis B	8.8e-05	0.00191	CbGpPWpGaD
Fluoxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	8.5e-05	0.00184	CbGpPWpGaD
Fluoxetine—ALB—Platelet activation, signaling and aggregation—HSPA5—hepatitis B	8.45e-05	0.00183	CbGpPWpGaD
Fluoxetine—HTR2C—G alpha (q) signalling events—F2—hepatitis B	8.37e-05	0.00181	CbGpPWpGaD
Fluoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	8.33e-05	0.00181	CbGpPWpGaD
Fluoxetine—ALB—Folate Metabolism—IL2—hepatitis B	8.09e-05	0.00175	CbGpPWpGaD
Fluoxetine—CYP2C19—Biological oxidations—GGT1—hepatitis B	7.82e-05	0.00169	CbGpPWpGaD
Fluoxetine—CYP1A2—Biological oxidations—CYP2A6—hepatitis B	7.81e-05	0.00169	CbGpPWpGaD
Fluoxetine—SLC6A4—NRF2 pathway—TGFB1—hepatitis B	7.73e-05	0.00168	CbGpPWpGaD
Fluoxetine—ALB—Folate Metabolism—NFKB1—hepatitis B	7.57e-05	0.00164	CbGpPWpGaD
Fluoxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	7.55e-05	0.00164	CbGpPWpGaD
Fluoxetine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	7.54e-05	0.00163	CbGpPWpGaD
Fluoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	7.49e-05	0.00162	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	7.38e-05	0.0016	CbGpPWpGaD
Fluoxetine—HTR2A—G alpha (q) signalling events—F2—hepatitis B	7.27e-05	0.00157	CbGpPWpGaD
Fluoxetine—ALB—Vitamin B12 Metabolism—TNF—hepatitis B	7.24e-05	0.00157	CbGpPWpGaD
Fluoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	7.23e-05	0.00157	CbGpPWpGaD
Fluoxetine—ALB—Selenium Micronutrient Network—IFNG—hepatitis B	7.23e-05	0.00157	CbGpPWpGaD
Fluoxetine—SLC6A4—Circadian rythm related genes—PTEN—hepatitis B	7.22e-05	0.00156	CbGpPWpGaD
Fluoxetine—CYP2D6—Biological oxidations—GGT1—hepatitis B	7.19e-05	0.00156	CbGpPWpGaD
Fluoxetine—CYP2C9—Biological oxidations—GGT1—hepatitis B	7.13e-05	0.00155	CbGpPWpGaD
Fluoxetine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	7.12e-05	0.00154	CbGpPWpGaD
Fluoxetine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	7.07e-05	0.00153	CbGpPWpGaD
Fluoxetine—ABCB1—Allograft Rejection—IFNG—hepatitis B	6.9e-05	0.0015	CbGpPWpGaD
Fluoxetine—SLC6A4—SIDS Susceptibility Pathways—TNF—hepatitis B	6.85e-05	0.00148	CbGpPWpGaD
Fluoxetine—SLC6A2—NRF2 pathway—TGFB1—hepatitis B	6.65e-05	0.00144	CbGpPWpGaD
Fluoxetine—SLC6A2—SLC-mediated transmembrane transport—ALB—hepatitis B	6.63e-05	0.00144	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	6.62e-05	0.00143	CbGpPWpGaD
Fluoxetine—HTR2A—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	6.55e-05	0.00142	CbGpPWpGaD
Fluoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	6.5e-05	0.00141	CbGpPWpGaD
Fluoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	6.46e-05	0.0014	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR ligand binding—CXCL10—hepatitis B	6.34e-05	0.00137	CbGpPWpGaD
Fluoxetine—ABCB1—Allograft Rejection—IL2—hepatitis B	6.14e-05	0.00133	CbGpPWpGaD
Fluoxetine—CYP1A2—Biological oxidations—GGT1—hepatitis B	6.09e-05	0.00132	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	6.04e-05	0.00131	CbGpPWpGaD
Fluoxetine—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	6.02e-05	0.00131	CbGpPWpGaD
Fluoxetine—ALB—Selenium Micronutrient Network—NFKB1—hepatitis B	6.01e-05	0.0013	CbGpPWpGaD
Fluoxetine—ALB—Folate Metabolism—TNF—hepatitis B	5.89e-05	0.00128	CbGpPWpGaD
Fluoxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	5.89e-05	0.00128	CbGpPWpGaD
Fluoxetine—ALB—Vitamin B12 Metabolism—IL6—hepatitis B	5.84e-05	0.00127	CbGpPWpGaD
Fluoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	5.61e-05	0.00122	CbGpPWpGaD
Fluoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	5.54e-05	0.0012	CbGpPWpGaD
Fluoxetine—SLC6A4—SIDS Susceptibility Pathways—IL6—hepatitis B	5.53e-05	0.0012	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—CXCL10—hepatitis B	5.51e-05	0.00119	CbGpPWpGaD
Fluoxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	5.5e-05	0.00119	CbGpPWpGaD
Fluoxetine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hepatitis B	5.5e-05	0.00119	CbGpPWpGaD
Fluoxetine—HTR2A—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	5.46e-05	0.00118	CbGpPWpGaD
Fluoxetine—ALB—Platelet degranulation—TGFB1—hepatitis B	5.41e-05	0.00117	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	5.39e-05	0.00117	CbGpPWpGaD
Fluoxetine—HTR2A—SIDS Susceptibility Pathways—NFKB1—hepatitis B	5.3e-05	0.00115	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	5.19e-05	0.00113	CbGpPWpGaD
Fluoxetine—ALB—Folate Metabolism—TP53—hepatitis B	5.19e-05	0.00112	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	5.16e-05	0.00112	CbGpPWpGaD
Fluoxetine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—hepatitis B	5.15e-05	0.00112	CbGpPWpGaD
Fluoxetine—SLC6A4—Circadian rythm related genes—TP53—hepatitis B	4.93e-05	0.00107	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR ligand binding—CCR5—hepatitis B	4.92e-05	0.00107	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—SAG—hepatitis B	4.87e-05	0.00106	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—RIT2—hepatitis B	4.87e-05	0.00106	CbGpPWpGaD
Fluoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	4.81e-05	0.00104	CbGpPWpGaD
Fluoxetine—ABCB1—Allograft Rejection—TGFB1—hepatitis B	4.79e-05	0.00104	CbGpPWpGaD
Fluoxetine—ALB—Folate Metabolism—IL6—hepatitis B	4.75e-05	0.00103	CbGpPWpGaD
Fluoxetine—CYP3A4—Biological oxidations—GGT1—hepatitis B	4.7e-05	0.00102	CbGpPWpGaD
Fluoxetine—ALB—Selenium Micronutrient Network—TNF—hepatitis B	4.68e-05	0.00101	CbGpPWpGaD
Fluoxetine—ALB—Platelet activation, signaling and aggregation—F2—hepatitis B	4.57e-05	0.000989	CbGpPWpGaD
Fluoxetine—SLC6A4—Circadian rythm related genes—IL6—hepatitis B	4.51e-05	0.000978	CbGpPWpGaD
Fluoxetine—ABCB1—Allograft Rejection—TNF—hepatitis B	4.47e-05	0.000968	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—HSPA5—hepatitis B	4.36e-05	0.000944	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—CCR5—hepatitis B	4.27e-05	0.000926	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—RIT2—hepatitis B	4.23e-05	0.000917	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—SAG—hepatitis B	4.23e-05	0.000917	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR ligand binding—F2—hepatitis B	4.22e-05	0.000915	CbGpPWpGaD
Fluoxetine—HTR2A—SIDS Susceptibility Pathways—TNF—hepatitis B	4.12e-05	0.000893	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—IFNB1—hepatitis B	3.93e-05	0.000851	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—AKR1B1—hepatitis B	3.9e-05	0.000846	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—IFNA1—hepatitis B	3.83e-05	0.00083	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—AKR1B1—hepatitis B	3.82e-05	0.000827	CbGpPWpGaD
Fluoxetine—ALB—Selenium Micronutrient Network—IL6—hepatitis B	3.78e-05	0.000818	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—GGT2—hepatitis B	3.74e-05	0.000811	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—F2—hepatitis B	3.67e-05	0.000794	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—GGT2—hepatitis B	3.66e-05	0.000792	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—CXCL10—hepatitis B	3.59e-05	0.000777	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—IFNA2—hepatitis B	3.57e-05	0.000773	CbGpPWpGaD
Fluoxetine—SLC6A2—Transmembrane transport of small molecules—ALB—hepatitis B	3.37e-05	0.000729	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	3.35e-05	0.000725	CbGpPWpGaD
Fluoxetine—HTR2A—SIDS Susceptibility Pathways—IL6—hepatitis B	3.33e-05	0.000721	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—AKR1B1—hepatitis B	3.29e-05	0.000712	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CXCL10—hepatitis B	3.26e-05	0.000705	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—GGT2—hepatitis B	3.15e-05	0.000682	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CXCL10—hepatitis B	3.11e-05	0.000675	CbGpPWpGaD
Fluoxetine—ALB—Platelet activation, signaling and aggregation—IL2—hepatitis B	3.07e-05	0.000666	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	3e-05	0.000651	CbGpPWpGaD
Fluoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	2.96e-05	0.000642	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—AKR1B1—hepatitis B	2.95e-05	0.000639	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	2.92e-05	0.000633	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—AKR1B1—hepatitis B	2.88e-05	0.000624	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	2.86e-05	0.000619	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	2.85e-05	0.000617	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	2.84e-05	0.000614	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—GGT2—hepatitis B	2.83e-05	0.000613	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CXCL10—hepatitis B	2.83e-05	0.000613	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—CCR5—hepatitis B	2.78e-05	0.000602	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GGT2—hepatitis B	2.76e-05	0.000598	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	2.74e-05	0.000593	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—AKR1B1—hepatitis B	2.71e-05	0.000588	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—AKR1B1—hepatitis B	2.69e-05	0.000583	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GGT2—hepatitis B	2.6e-05	0.000564	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GGT2—hepatitis B	2.58e-05	0.000559	CbGpPWpGaD
Fluoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	2.57e-05	0.000558	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CCR5—hepatitis B	2.52e-05	0.000547	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CCR5—hepatitis B	2.41e-05	0.000523	CbGpPWpGaD
Fluoxetine—ALB—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	2.4e-05	0.00052	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—F2—hepatitis B	2.39e-05	0.000517	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	2.36e-05	0.000512	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—F2—hepatitis B	2.35e-05	0.00051	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	2.34e-05	0.000507	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—NOS2—hepatitis B	2.33e-05	0.000504	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—AKR1B1—hepatitis B	2.3e-05	0.000498	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—CYP2A6—hepatitis B	2.27e-05	0.000491	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—CYP2A6—hepatitis B	2.22e-05	0.00048	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	2.21e-05	0.000478	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GGT2—hepatitis B	2.2e-05	0.000477	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CCR5—hepatitis B	2.19e-05	0.000475	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—F2—hepatitis B	2.17e-05	0.000469	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—F2—hepatitis B	2.07e-05	0.000449	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—GOT2—hepatitis B	2.05e-05	0.000444	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—GOT2—hepatitis B	2e-05	0.000434	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	1.94e-05	0.000421	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CXCL10—hepatitis B	1.92e-05	0.000417	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—CYP2A6—hepatitis B	1.91e-05	0.000413	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—F2—hepatitis B	1.88e-05	0.000408	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—AKR1B1—hepatitis B	1.77e-05	0.000384	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—GOT1—hepatitis B	1.77e-05	0.000383	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—GGT1—hepatitis B	1.77e-05	0.000383	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—GGT1—hepatitis B	1.73e-05	0.000375	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—GOT1—hepatitis B	1.73e-05	0.000375	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—GOT2—hepatitis B	1.73e-05	0.000374	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CYP2A6—hepatitis B	1.71e-05	0.000371	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GGT2—hepatitis B	1.7e-05	0.000368	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CYP2A6—hepatitis B	1.67e-05	0.000362	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CXCL10—hepatitis B	1.67e-05	0.000362	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—IL2—hepatitis B	1.61e-05	0.000348	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.6e-05	0.000346	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—IL2—hepatitis B	1.58e-05	0.000343	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CYP2A6—hepatitis B	1.58e-05	0.000341	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CYP2A6—hepatitis B	1.56e-05	0.000338	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—GOT2—hepatitis B	1.55e-05	0.000336	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GOT2—hepatitis B	1.51e-05	0.000328	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CCR5—hepatitis B	1.49e-05	0.000323	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—GOT1—hepatitis B	1.49e-05	0.000323	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—GGT1—hepatitis B	1.49e-05	0.000323	CbGpPWpGaD
Fluoxetine—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	1.48e-05	0.000321	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—IL2—hepatitis B	1.46e-05	0.000316	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.46e-05	0.000316	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GOT2—hepatitis B	1.43e-05	0.000309	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GOT2—hepatitis B	1.41e-05	0.000306	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—IL2—hepatitis B	1.4e-05	0.000302	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.36e-05	0.000294	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—GOT1—hepatitis B	1.34e-05	0.00029	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—GGT1—hepatitis B	1.34e-05	0.00029	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CYP2A6—hepatitis B	1.33e-05	0.000289	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GOT1—hepatitis B	1.31e-05	0.000283	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GGT1—hepatitis B	1.31e-05	0.000283	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CCR5—hepatitis B	1.3e-05	0.000281	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—F2—hepatitis B	1.28e-05	0.000277	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—IL2—hepatitis B	1.27e-05	0.000274	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.24e-05	0.00027	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—TGFB1—hepatitis B	1.24e-05	0.000268	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GGT1—hepatitis B	1.23e-05	0.000267	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GOT1—hepatitis B	1.23e-05	0.000267	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GGT1—hepatitis B	1.22e-05	0.000264	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GOT1—hepatitis B	1.22e-05	0.000264	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.22e-05	0.000264	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GOT2—hepatitis B	1.21e-05	0.000262	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.11e-05	0.000241	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—F2—hepatitis B	1.11e-05	0.000241	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GOT1—hepatitis B	1.04e-05	0.000226	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GGT1—hepatitis B	1.04e-05	0.000226	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CYP2A6—hepatitis B	1.03e-05	0.000223	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—TP53—hepatitis B	1.02e-05	0.000221	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	9.5e-06	0.000206	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ALB—hepatitis B	9.41e-06	0.000204	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GOT2—hepatitis B	9.32e-06	0.000202	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ALB—hepatitis B	9.2e-06	0.000199	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—IL2—hepatitis B	8.62e-06	0.000187	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—IL6—hepatitis B	8.57e-06	0.000186	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CTNNB1—hepatitis B	8.32e-06	0.00018	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CDKN1A—hepatitis B	8.13e-06	0.000176	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—PTEN—hepatitis B	8.11e-06	0.000176	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NFKB1—hepatitis B	8.07e-06	0.000175	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GOT1—hepatitis B	8.04e-06	0.000174	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GGT1—hepatitis B	8.04e-06	0.000174	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—IL2—hepatitis B	7.48e-06	0.000162	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—IL6—hepatitis B	7.45e-06	0.000161	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CTNNB1—hepatitis B	7.22e-06	0.000157	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—PTEN—hepatitis B	7.18e-06	0.000156	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ALB—hepatitis B	7.11e-06	0.000154	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CDKN1A—hepatitis B	7.06e-06	0.000153	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—PTEN—hepatitis B	7.04e-06	0.000153	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—PTEN—hepatitis B	7.02e-06	0.000152	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NFKB1—hepatitis B	7.01e-06	0.000152	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ALB—hepatitis B	6.94e-06	0.00015	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—TGFB1—hepatitis B	6.72e-06	0.000146	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ALB—hepatitis B	6.54e-06	0.000142	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ALB—hepatitis B	6.49e-06	0.000141	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PTEN—hepatitis B	6.05e-06	0.000131	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—TGFB1—hepatitis B	5.84e-06	0.000126	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ALB—hepatitis B	5.54e-06	0.00012	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—TP53—hepatitis B	5.53e-06	0.00012	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PTEN—hepatitis B	5.43e-06	0.000118	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PTEN—hepatitis B	5.3e-06	0.000115	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—IL6—hepatitis B	5.07e-06	0.00011	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PTEN—hepatitis B	4.99e-06	0.000108	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PTEN—hepatitis B	4.95e-06	0.000107	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—TP53—hepatitis B	4.81e-06	0.000104	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—IL6—hepatitis B	4.4e-06	9.53e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ALB—hepatitis B	4.28e-06	9.27e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PTEN—hepatitis B	4.23e-06	9.16e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PTEN—hepatitis B	3.26e-06	7.07e-05	CbGpPWpGaD
